MFDS
- Marketing authorisation holder: MEDPOINTE PHARM HLC
- Status: likely_approved
🇰🇷 Mebutina in South Korea
Mebutina (MEBUTAMATE) regulatory status in South Korea.
Marketing authorisation
Mebutina in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in South Korea
Frequently asked questions
Is Mebutina approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Mebutina in South Korea?
MEDPOINTE PHARM HLC holds the South Korean marketing authorisation.